Berinert, human plasma-derived, purified, pasteurized concentrate of the protein C1 esterase inhibitor, is specifically indicated for the treatment of acute facial or abdominal attacks of hereditary angioedema (HAE) in adult and adolescent patients.

Iprivask (desirudin for injection), a direct thrombin inhibitor, has been made available for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism, in patients undergoing elective hip replacement surgery.

Thrombate III, a preparation of antithrombin concentrate purified from human plasma, is indicated for the treatment of patients with hereditary antithrombin deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism.